REQUEST A DEMO
Total
USD $0.00
Search more companies

Liminal Therapeutics S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Liminal Therapeutics S A S Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Liminal Therapeutics S A S is based in Colombia, with the head office in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on June 21, 2011. It currently has a total number of 2 (2017) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 31.1% in 2023. Its total assets decreased by 0.54% over the same period. In 2023, Liminal Therapeutics S A S’s net profit margin increased by 2.55%.

Headquarters
Cr 13 29 41 Manzana 1 Of 220
Bogota D.C.; Bogota D.C; Postal Code: 0130

Contact Details: Purchase the Liminal Therapeutics S A S report to view the information.

Basic Information
Total Employees:
Purchase the Liminal Therapeutics S A S report to view the information.
Outstanding Shares:
Purchase the Liminal Therapeutics S A S report to view the information.
Incorporation Date:
June 21, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Liminal Therapeutics S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.1%
Total operating revenue
31.1%
Operating profit (EBIT)
69.86%
Net Profit (Loss) for the Period
82.71%
Total assets
-0.54%
Total equity
28.82%
Operating Profit Margin (ROS)
3.17%
Net Profit Margin
2.55%
Return on Equity (ROE)
6.6%
Quick Ratio
0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?